Status:
COMPLETED
Dialectical Behavior Therapy vs Enhanced Usual Care for Suicidal and Self-harming Adolescents. 10 Year Follow-up
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
University of Oslo
Conditions:
Self-Harm, Deliberate
Borderline Personality Disorder
Eligibility:
All Genders
22-30 years
Phase:
NA
Brief Summary
The purpose of the study is to evaluate the long-term efficacy of dialectical behavior therapy (DBT) in treatment of adolescents with deliberate self harm compared to enhanced usual care (EUC). This s...
Detailed Description
Suicide attempts and non-suicidal self-harm, highly prevalent in adolescents, are behaviours strongly associated with severe emotion dysregulation, mental health problems and increased suicide risk. T...
Eligibility Criteria
Inclusion
- The inclusion criteria for the initial study were:
- History of repeated self-harm (last episode within last 4 months) and
- Age between 12 and 18 years and
- Satisfied at least 2 criteria of DSM-IV Borderline Personality Disorder (BPD) (as measured by the SCIDII) (in addition to the self-destructive criterion) - alternatively at least 1 criterion of DSM-IV BPD plus at least 2 threshold level criteria and
- Written informed consent from patient and parent(s) to participate in the study and
- Patient fluently Norwegian speaking
- Exclusion Criteria:
- Psychotic disorders or
- Anorexia nervosa or
- Severe substance dependence disorders or
- Mental retardation (IQ less than 70) or
- Asperger syndrome/autism -
Exclusion
Key Trial Info
Start Date :
May 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT04298190
Start Date
May 15 2022
End Date
April 30 2023
Last Update
November 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Centre for Suicide Research and Prevention Unit/University of Oslo
Oslo, Norway, 0372